News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
596,047 Results
Type
Article (41633)
Company Profile (97)
Press Release (554317)
Multimedia
Podcasts (62)
Webinars (14)
Section
Business (162509)
Career Advice (2444)
Deals (29682)
Drug Delivery (104)
Drug Development (73701)
Employer Resources (146)
FDA (14413)
Job Trends (13274)
News (286323)
Policy (28399)
Tag
Academia (2629)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (83)
Alliances (41692)
ALS (92)
Alzheimer's disease (1407)
Antibody-drug conjugate (ADC) (132)
Approvals (14406)
Artificial intelligence (270)
Autoimmune disease (22)
Automation (16)
Bankruptcy (319)
Best Places to Work (10887)
BIOSECURE Act (17)
Biosimilars (105)
Biotechnology (69)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (269)
Cancer (2185)
Cardiovascular disease (186)
Career advice (2057)
Career pathing (32)
CAR-T (142)
Cell therapy (400)
Cervical cancer (17)
Clinical research (60109)
Collaboration (760)
Compensation (279)
Complete response letters (23)
COVID-19 (2546)
CRISPR (42)
C-suite (257)
Cystic fibrosis (86)
Data (2134)
Decentralized trials (2)
Denatured (15)
Depression (50)
Diabetes (265)
Diagnostics (6209)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (121)
Drug pricing (105)
Drug shortages (23)
Duchenne muscular dystrophy (96)
Earnings (58279)
Editorial (41)
Employer branding (19)
Employer resources (132)
Events (97907)
Executive appointments (738)
FDA (15600)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (701)
Gene editing (103)
Generative AI (26)
Gene therapy (304)
GLP-1 (713)
Government (4334)
Grass and pollen (5)
Guidances (57)
Healthcare (18101)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (131)
Indications (29)
Infectious disease (2695)
Inflammatory bowel disease (130)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (89)
Interviews (522)
IPO (13283)
IRA (44)
Job creations (2805)
Job search strategy (1684)
Kidney cancer (11)
Labor market (20)
Layoffs (430)
Leadership (23)
Legal (6167)
Liver cancer (73)
Lung cancer (326)
Lymphoma (145)
Machine learning (6)
Management (53)
Manufacturing (262)
MASH (73)
Medical device (12051)
Medtech (12055)
Mergers & acquisitions (16914)
Metabolic disorders (685)
Multiple sclerosis (78)
NASH (23)
Neurodegenerative disease (99)
Neuropsychiatric disorders (32)
Neuroscience (1956)
NextGen: Class of 2025 (6186)
Non-profit (4239)
Now hiring (31)
Obesity (355)
Opinion (221)
Ovarian cancer (73)
Pain (86)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (17)
Patents (218)
Patient recruitment (105)
Peanut (45)
People (53479)
Pharmaceutical (29)
Pharmacy benefit managers (14)
Phase I (18470)
Phase II (26406)
Phase III (20243)
Pipeline (1162)
Policy (137)
Postmarket research (2360)
Preclinical (7527)
Press Release (55)
Prostate cancer (104)
Psychedelics (37)
Radiopharmaceuticals (234)
Rare diseases (375)
Real estate (4516)
Recruiting (58)
Regulatory (19942)
Reports (25)
Research institute (2230)
Resumes & cover letters (357)
Rett syndrome (5)
RNA editing (4)
RSV (42)
Schizophrenia (75)
Series A (123)
Series B (82)
Service/supplier (4)
Sickle cell disease (56)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (28)
Startups (3007)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (32)
The Weekly (46)
Vaccines (659)
Venture capitalists (36)
Weight loss (238)
Women's health (30)
Worklife (18)
Date
Today (139)
Last 7 days (775)
Last 30 days (2400)
Last 365 days (30759)
2025 (9984)
2024 (32901)
2023 (36920)
2022 (47654)
2021 (51734)
2020 (50411)
2019 (43655)
2018 (32932)
2017 (28803)
2016 (28049)
2015 (32954)
2014 (25125)
2013 (20535)
2012 (21831)
2011 (22752)
2010 (20128)
Location
Africa (770)
Alabama (51)
Alaska (4)
Arizona (166)
Arkansas (12)
Asia (35568)
Australia (7138)
California (5459)
Canada (1895)
China (482)
Colorado (248)
Connecticut (236)
Delaware (137)
Europe (80457)
Florida (847)
Georgia (199)
Hawaii (1)
Idaho (52)
Illinois (509)
India (24)
Indiana (294)
Iowa (7)
Japan (156)
Kansas (88)
Kentucky (21)
Louisiana (11)
Maine (59)
Maryland (825)
Massachusetts (4017)
Michigan (223)
Minnesota (338)
Mississippi (2)
Missouri (89)
Montana (22)
Nebraska (23)
Nevada (58)
New Hampshire (65)
New Jersey (1605)
New Mexico (22)
New York (1579)
North Carolina (880)
North Dakota (6)
Northern California (2383)
Ohio (184)
Oklahoma (9)
Oregon (27)
Pennsylvania (1267)
Puerto Rico (13)
Rhode Island (29)
South America (1044)
South Carolina (20)
South Dakota (1)
Southern California (2093)
Tennessee (94)
Texas (820)
United States (20878)
Utah (178)
Virginia (140)
Washington D.C. (59)
Washington State (508)
West Virginia (3)
Wisconsin (48)
596,047 Results for "siemens healthineers formerly known as siemens healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
March 31, 2025
·
2 min read
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
Profound Medical Corp. announced that it has entered into a non-exclusive collaboration with Siemens Healthineers, a global leader in medical technology.
February 27, 2024
·
7 min read
Press Releases
Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
December 1, 2024
·
8 min read
Press Releases
InkSpace Imaging Receives FDA 510(k) Clearance for 1.5T 24-channel MR Coil for Siemens Healthineers
January 8, 2025
·
2 min read
Press Releases
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
September 26, 2024
·
6 min read
BioMidwest
Stratasys Partners with Siemens Healthineers in Landmark Research Project to Advance Medical Imaging
Stratasys Ltd. announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography imaging.
November 27, 2023
·
4 min read
Biotech Bay
InkSpace Imaging receives FDA Clearance for a 24-channel Small Body Array Compatible with Siemens Healthineers 3T Systems
InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners.
January 11, 2024
·
2 min read
News
Quantek Systems and Varian, a Siemens Healthineers Company, Announce Strategic Collaboration to Enhance Clinical Interoperability
July 16, 2024
·
2 min read
Biotech Bay
Together with Siemens Healthineers, Varian Demonstrates Commitment to Embracing Innovation and Enhancing Outcomes at ASTRO 2023
Varian, a Siemens Healthineers company, is showcasing technologies that reflect its continued commitment to embracing innovation and enhancing outcomes for cancer patients at this year’s 2023 American Society for Radiation Oncology annual meeting, taking place from October 1-4 in San Diego, California.
September 28, 2023
·
5 min read
FDA
Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer1 for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets.
July 20, 2023
·
4 min read
1 of 59,605
Next
